- Home
- WST vs EL Comparison
WST vs EL Comparison
Compare WST & EL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WST
- EL
- Stock Information
- Founded
- WST 1923
- EL 1946
- Country
- WST United States
- EL United States
- Employees
- WST N/A
- EL N/A
- Industry
- WST Medical/Dental Instruments
- EL Package Goods/Cosmetics
- Sector
- WST Health Care
- EL Consumer Discretionary
- Exchange
- WST Nasdaq
- EL Nasdaq
- Market Cap
- WST 18.9B
- EL 33.0B
- IPO Year
- WST N/A
- EL 1995
- Fundamental
- Price
- WST $258.35
- EL $88.54
- Analyst Decision
- WST Strong Buy
- EL Buy
- Analyst Count
- WST 8
- EL 20
- Target Price
- WST $329.43
- EL $88.20
- AVG Volume (30 Days)
- WST 549.8K
- EL 3.9M
- Earning Date
- WST 10-23-2025
- EL 10-30-2025
- Dividend Yield
- WST 0.34%
- EL 1.59%
- EPS Growth
- WST N/A
- EL N/A
- EPS
- WST 6.68
- EL N/A
- Revenue
- WST $2,960,200,000.00
- EL $14,326,000,000.00
- Revenue This Year
- WST $6.28
- EL $6.13
- Revenue Next Year
- WST $6.02
- EL $4.22
- P/E Ratio
- WST $38.69
- EL N/A
- Revenue Growth
- WST 2.90
- EL N/A
- 52 Week Low
- WST $187.43
- EL $48.37
- 52 Week High
- WST $352.33
- EL $103.44
- Technical
- Relative Strength Index (RSI)
- WST 60.16
- EL 49.62
- Support Level
- WST $253.38
- EL $83.45
- Resistance Level
- WST $264.06
- EL $88.42
- Average True Range (ATR)
- WST 5.67
- EL 2.46
- MACD
- WST 0.60
- EL -0.44
- Stochastic Oscillator
- WST 74.53
- EL 49.37
About WST West Pharmaceutical Services Inc.
West Pharmaceutical Services is based in Pennsylvania, US, and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), non-glass containment solutions, and auto-injectors for injectable drugs, which include large molecule biologics, peptides such as GLP-1 receptor agonists, and small molecule drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.
About EL Estee Lauder Companies Inc. (The)
Estée Lauder is a leader in the global prestige beauty market, participating across skin care (49% of fiscal 2025 sales), makeup (29%), fragrance (17%), and hair care and others (5%), with top-selling brands such as Estée Lauder, Clinique, M.A.C, La Mer, Jo Malone London, Aveda, Bobbi Brown, and Origins. The firm operates in more than 150 countries, generating 31% of revenue from the Americas, 37% from Europe, the Middle East and Africa (including travel retail), and 32% from Asia-Pacific. Estée Lauder sells its products through department stores, travel retail, specialty multibrand beauty stores, brand-dedicated freestanding stores, e-commerce, salons/spas, and perfumeries.